Prelude Capital Management’s Medicines Co MDCO Stock Holding History

Prelude Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,300	Closed	-$875K	–	2318
2019 Q4	$875K	Buy	10,300 +8,400	+442%	+$560K	0.03%	426
2019 Q3	$95K	Buy	+1,900	New	+$75.8K	﹤0.01%	974
2013 Q4	–	Sell	-12,000	Closed	-$402K	–	2051
2013 Q3	$402K	Buy	+12,000	New	+$382K	0.06%	347

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Prelude Capital Management's MDCO Position: Q1 2020 in Review

Prelude Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 139,534 shares — an estimated $11.9M sold.

Prelude Capital Management first reported a position in MDCO in Q3 2013 and held it in 10 quarters. The position peaked at $11.9M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Prelude Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Prelude Capital Management sold 139,534 Medicines Co shares in Q1 2020, an estimated $11.9M.
Prelude Capital Management first reported a position in Medicines Co in Q3 2013 and held it in 10 quarters.
Prelude Capital Management's Medicines Co position peaked at $11.9M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.